Nature Search

Author Correction: Treatment in myositis

Chester V. Oddis
Rohit Aggarwal
Amendments and Corrections11 Sept 2018
Nature Reviews Rheumatology

Volume: 14, P: 619
Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative

Alexander G. S. Oldroyd
Jeffrey P. Callen
Rohit Aggarwal
Amendments and Corrections28 Mar 2024
Nature Reviews Rheumatology

Volume: 20, P: 315
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer

A multiomic approach profiles the three-dimensional, epigenetic and mutational landscapes of 80 metastatic prostate cancer biopsies. Hi-C experiments identify an extrachromosomal circular DNA at the AR locus associated with therapy resistance.

Shuang G. Zhao
Matthew Bootsma
Felix Y. Feng
ResearchOpen Access17 Jul 2024
Nature Genetics

Volume: 56, P: 1689-1700
The DNA methylation landscape of advanced prostate cancer

Whole-genome bisulfite sequencing along with whole-genome and transcriptome sequencing of 100 prostate cancer metastases identifies genomic regions that are differentially methylated during disease progression and a novel epigenomic subtype.

Shuang G. Zhao
William S. Chen
Felix Y. Feng
Research13 Jul 2020
Nature Genetics

Volume: 52, P: 778-789
Update on outcome assessment in myositis

The idiopathic inflammatory myopathies are characterized by muscle weakness and inflammation. A range of tools are available to evaluate outcomes in the treatment of myositis, including, among others, core set measures that were developed by international networks of myositis researchers.

Lisa G. Rider
Rohit Aggarwal
Nicolino Ruperto
Reviews12 Apr 2018
Nature Reviews Rheumatology

Volume: 14, P: 303-318
International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative

In this Evidence-Based Guideline article, an international, multidisciplinary group of experts presents evidence-based consensus recommendations on screening for cancer in patients with adult-onset idiopathic inflammatory myopathy, addressing cancer risk stratification, screening modalities and screening frequency.

Alexander G. S. Oldroyd
Jeffrey P. Callen
Rohit Aggarwal
Reviews09 Nov 2023
Nature Reviews Rheumatology

Volume: 19, P: 805-817
Optical coherence tomography angiography (OCTA) of retinal vasculature in patients with post fever retinitis: a qualitative and quantitative analysis

Srinivasan Sanjay
Santosh Gopi Krishna Gadde
Rohit Shetty
ResearchOpen Access03 Sept 2021
Scientific Reports

Volume: 11, P: 1-12
Idiopathic inflammatory myopathies

Idiopathic inflammatory myopathies, also known as myositis, are a heterogeneous group of autoimmune disorders usually characterized by chronic inflammation of the muscle. This Primer reviews the epidemiology, pathophysiology, diagnosis, treatment, patient quality of life and future research needs of this group of diseases.

Ingrid E. Lundberg
Manabu Fujimoto
Frederick W. Miller
Reviews02 Dec 2021
Nature Reviews Disease Primers

Volume: 7, P: 1-22
Treatment in myositis

Many immunosuppressive and immunomodulatory therapies are available to clinicians for managing myositis, and numerous biologic and small-molecule therapies are emerging that target implicated pathogenic targets. However, care must be taken when considering the numerous extramuscular complications of this disease.

Chester V. Oddis
Rohit Aggarwal
Reviews29 Mar 2018
Nature Reviews Rheumatology

Volume: 14, P: 279-289

Search

Filter By:

Search

Quick links